Bullae are elevated, fluid-filled blisters ≥ 10 mm in diameter.
(Synonyms of mucous membrane pemphigoid that are no longer used include cicatricial pemphigoid, ocular cicatricial pemphigoid, and benign mucous membrane pemphigoid.)
Oral mucous membrane pemphigoid and ocular mucous membrane pemphigoid Ocular Mucous Membrane Pemphigoid Ocular mucous membrane pemphigoid is a chronic, bilateral, progressive scarring and shrinkage of the conjunctiva with opacification of the cornea. Early symptoms are hyperemia and irritation... read more are typical, but other mucosal sites and the skin (usually of the head and upper trunk) may be involved. Older people are most often affected, women more than men.
Mucous membrane pemphigoid (MMP) is characterized by subepithelial lesions caused by autoantibodies against molecules of epithelial basement membranes. The target molecules lie deeper than those of bullous pemphigoid Bullous Pemphigoid Bullous pemphigoid is a chronic autoimmune skin disorder resulting in generalized, pruritic, bullous lesions in older patients. Mucous membrane involvement is rare. Diagnosis is by skin biopsy... read more . Several autoantibodies have been identified, including those against BPAG2, laminin-332, and type VII collagen. Antibodies to beta-4 integrin have been identified in generalized MMP and ocular MMP, and antibodies to alpha-6 integrin have been identified in oral MMP.
Diagnosis of Mucous Membrane Pemphigoid
Skin biopsy and direct immunofluorescence
Prevalent mucosal involvement and scarring lesions help distinguish MMP from bullous pemphigoid. Diagnosis of mucous membrane pemphigoid is supported by lesion biopsy and direct immunofluorescence. Linear basement membrane deposits may include IgG, IgA, and C3. Serum autoantibodies tend to be absent or at low titre.
Prognosis for Mucous Membrane Pemphigoid
Mucous membrane pemphigoid progresses slowly, rarely remits spontaneously, and often responds incompletely to treatment. Depending on the site affected, serious sequelae may include ocular damage and blindness, airway erosions and destruction, and strictures of the esophagus or anogenital regions. Patients with anti-laminin-332 MMP have an increased risk of internal cancer; if this form is suspected (eg, by immunofluorescence results), patients should be screened for cancers common to their age and sex.
Treatment of Mucous Membrane Pemphigoid
For mild disease, corticosteroids and doxycycline plus nicotinamide
For severe disease, systemic immunosuppression
Treatment of mucous membrane pemphigoid is similar to that for bullous pemphigoid Treatment Bullous pemphigoid is a chronic autoimmune skin disorder resulting in generalized, pruritic, bullous lesions in older patients. Mucous membrane involvement is rare. Diagnosis is by skin biopsy... read more . Topical or intralesional corticosteroids and a combination of oral doxycycline 100 mg orally twice a day and nicotinamide 500 mg orally 3 times a day may be useful for milder cases.
Severe disease may require systemic immunosuppression with dapsone or prednisone or sometimes high-dose prednisone with immunosuppressants (eg, azathioprine, mycophenolate, cyclophosphamide, rituximab) and IV immune globulin.
Drugs Mentioned In This Article
|Drug Name||Select Trade|
|Acticlate, Adoxa, Adoxa Pak, Avidoxy, Doryx, Doxal, Doxy 100, LYMEPAK, Mondoxyne NL, Monodox, Morgidox 1x, Morgidox 2x , Okebo, Oracea, Oraxyl, Periostat, TARGADOX, Vibramycin, Vibra-Tabs|
|Deltasone, Predone, RAYOS, Sterapred, Sterapred DS|
|Cyclophosphamide, Cytoxan, Neosar|
|RIABNI, Rituxan, RUXIENCE, truxima|